Scarica l'app Stockscreener
2.45
4.67%
-0.12
Precedente Chiudi:
$2.57
Aprire:
$2.51
Volume 24 ore:
14,664
Relative Volume:
0.25
Capitalizzazione di mercato:
$93.63M
Reddito:
$1.54M
Utile/perdita netta:
$-8.87M
Rapporto P/E:
-0.069
EPS:
-35.4915
Flusso di cassa netto:
$-2.74M
1 W Prestazione:
-3.92%
1M Prestazione:
+10.36%
6M Prestazione:
-82.81%
1 anno Prestazione:
-99.03%
Intervallo 1D:
$2.45
$2.55
Intervallo di 1 settimana:
$2.2001
$2.73
Portata 52W:
$1.2501
$1,046.98
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
Compare SXTC vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SXTC
China Sxt Pharmaceuticals Inc
|
2.45 | 98.22M | 1.54M | -8.87M | -2.74M | -35.49 |
TAK
Takeda Pharmaceutical Co Adr
|
17.15 | 53.43B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
10.10 | 44.52B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.03 | 37.52B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.56 | 32.24B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
535.67 | 22.46B | 3.17B | 1.29B | 1.01B | 27.09 |
China Sxt Pharmaceuticals Inc Borsa (SXTC) Ultime notizie
China SXT Pharmaceuticals (SXTC) Edges Lower as Stock Hovers Near Support – $2.55 BeckonsPSAR Stop - dars.gov.et
China Sxt Pharmaceuticals Files Resale Registration for Up to 157.5 Million Shares - Moomoo
China SXT (SXTC) registers 157.5M-share resale linked to $31.5M pre-paid facility - Stock Titan
China SXT Pharmaceuticals Secures Up to $30 Million in New Pre‑Paid Share Financing - TipRanks
China SXT Pharmaceuticals (NASDAQ: SXTC) agrees to up to $30M pre-paid share facility - Stock Titan
China SXT Pharmaceuticals (SXTC) Hovers Near Support After Modest DeclineMomentum ETF - dars.gov.et
China SXT Pharmaceuticals, Inc. announced that it expects to receive $28.56 million in funding - marketscreener.com
China SXT (NASDAQ: SXTC) 20-F outlines VIE, dual-class shares and China risk - Stock Titan
China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2026 - marketscreener.com
Enterprise value to EBITDA forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Price to sales forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Enterprise value to revenue forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Price to book forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Price to earnings forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Enterprise value to EBIT forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
China SXT Pharmaceuticals Inc (SXTC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
China SXT Pharmaceuticals (SXTC) Consolidates Near Resistance After Modest GainGEX Level - dars.gov.et
China SXT Pharmaceuticals Inc (SXTC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
China SXT Pharmaceuticals Inc - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Institutional Confidence - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Valuation: PE, PB & Fair Value Analysis - TradingKey
China SXT Pharmaceuticals Company Profile & Introduction - Moomoo
China SXT Pharmaceuticals Shares Surge Over 25% After Hours: Here's Why - Sahm
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
China SXT Pharmaceuticals shares surge over 25% after hours: Here's why - MSN
China SXT Pharmaceuticals Launches $100 Million ATM Equity Program with Univest Securities - The Globe and Mail
China SXT Pharmaceuticals (SXTC) launches $100M ATM offering with Univest - Stock Titan
China SXT (NASDAQ: SXTC) sets up $100M at-the-market share offering - Stock Titan
SXTCChina SXT Pharmaceuticals Inc Latest SEC Filings - Finviz
China SXT Pharmaceuticals (SXTC) Surges 7%: Potential Breakout Above ResistanceTake Profit Levels - DonanımHaber
China SXT Pharmaceuticals (SXTC) Slips 3% as Stock Tests Key Support LevelsDip Buy Trade - dars.gov.et
SXTC Faces Selling Pressure: Key Levels to Watch After 7.3% DeclineSector Neutral Pair - dars.gov.et
China SXT Pharmaceuticals (SXTC) Sees Uptick Amid Support HoldingVolume Rate Change - Newser
SXTC Should I Buy - Intellectia AI
TradingKey - TradingKey
SXTC Technical Analysis | Trend, Signals & Chart Patterns | CHINA SXT PHARMACEUTICALS-A (NASDAQ:SXTC) - ChartMill
China SXT Pharmaceuticals Raises $3.5 Million in Offshore Private Placement - The Globe and Mail
China SXT Pharmaceuticals Inc (SXTC) - MSN
China SXT (NASDAQ: SXTC) prices $3.5M Reg S share and warrant deal - Stock Titan
MSN Money - MSN
SXTC Stock Price, Quote & Chart | CHINA SXT PHARMACEUTICALS-A (NASDAQ:SXTC) - ChartMill
What guidance trend China SXT (SXTC)? (Bearish Momentum) 2026-04-29Volume Breakout - newser.com
China SXT Pharmaceuticals (SXTC) Co-CEO reports indirect Class B stake - Stock Titan
China SXT Pharmaceuticals (SXTC) CFO listed as insider in Form 3 - Stock Titan
China SXT Pharmaceuticals (SXTC) director Chee Yong Lip files Form 3 - Stock Titan
Director Ji Xiaodong files Form 3 for China SXT (SXTC) - Stock Titan
Director Liu Tong Tony files Form 3 at China SXT (SXTC) - Stock Titan
China Sxt Pharmaceuticals Inc Azioni (SXTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.50%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):